SCHEMBL6986836

SCHEMBL6986836

Cc1n[c][nH]c1-c1cccnc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP11B1 P15538 1/20 0.47
CYP11B2 P19099 1/20 0.47
CYP2A6 P11509 12/20 0.47
CYP3A4 P08684 5/20 0.47
ALDH1A1 P00352 3/20 0.47
CYP1A2 P05177 1/20 0.47
ALK Q9UM73 1/20 0.42
KDM4E B2RXH2 1/20 0.41
LMNA P02545 1/20 0.41
TP53 P04637 1/20 0.41
MAPT P10636 1/20 0.41
HPGD P15428 1/20 0.41
ALOX15 P16050 1/20 0.41
HTT P42858 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
HSD17B10 Q99714 1/20 0.41
NISCH Q9Y2I1 1/20 0.41
CYP2E1 P05181 4/20 0.40
CYP2B6 P20813 4/20 0.40
CYP2D6 P10635 3/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL557663 0.80 KDM4E (0.41) CYP3A4ALDH1A1KDM4ELMNAMAPT
SCHEMBL6988367 0.78 ATM (0.31)
SCHEMBL7356788 0.76 CYP2A6 (0.50) CYP11B1CYP11B2CYP2A6CYP3A4ALDH1A1
SCHEMBL4045129 0.73 GPR55 (0.43) CYP11B1CYP11B2CYP2A6CYP3A4ALDH1A1
SCHEMBL27674566 0.70 CYP11B1 (0.49) CYP11B1CYP11B2CYP2A6CYP3A4ALDH1A1
SCHEMBL13102550 0.70 CYP11B1 (0.49) CYP11B1CYP11B2CYP2A6CYP3A4ALDH1A1
SCHEMBL7585127 0.69 CYP2A6 (0.52) CYP11B1CYP11B2CYP2A6CYP3A4ALDH1A1
SCHEMBL1116552 0.68 CYP11B1 (0.54) CYP11B1CYP11B2CYP2A6CYP3A4ALDH1A1
SCHEMBL29419014 0.67 CYP2A6 (1.00) CYP11B1CYP11B2CYP2A6CYP3A4ALDH1A1
SCHEMBL30473120 0.67 CYP2A6 (1.00) CYP11B1CYP11B2CYP2A6CYP3A4ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1337251-A1 MONOCYCLIC OR BICYCLIC CARBOCYCLES AND HETEROCYCLES AS FACTOR XA INHIBITORS Bristol-Myers Squibb Pharma Company (US) 2003-08-27 EP disclosed
WO-2002102380-A1 MONOCYCLIC OR BICYCLIC CARBOCYCLES AND HETEROCYCLES AS FACTOR XA INHIBITORS BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) 2002-12-27 WO disclosed